Abstract

The current study evaluated the in-vitro antibacterial activity of Celtis timorensis Span. (C. timorensis) against Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), and Staphylococcus aureus (ATCC 25923) in response to the global healthcare challenge of infectious diseases caused by Multidrug Resistance organisms. The study was motivated by the inappropriate use of existing antimicrobials and the insufficient discovery of new agents contributing to this crisis. Drawing inspiration from historical evidence in plant-based Ayurveda and traditional medicine, the study focused on C. timorensis, a plant known for its historical use in treating infectious diseases.
 Crude extracts from the leaves, bark, and stem of C. timorensis were prepared using the cold maceration process, and their antibacterial activity was assessed against the aforementioned bacterial strains. The cylinder plate method was employed to measure zones of inhibition at various concentrations (250 µg/ml, 500 µg/ml, 750 µg/ml, and 1000 µg/ml). Positive and negative controls included Gentamicin and distilled water respectively. The diameter of inhibition zones was measured after 24 hours of incubation.
 Results indicated positive antibacterial effects of all three extracts against E. coli (ATCC 25922) and P. aeruginosa (ATCC 27853). Notably, aqueous extraction from the stem exhibited the highest inhibitory zones against E. coli and P. aeruginosa. However, none of the concentrations of the extracts showed positive antibacterial effects against S. aureus (ATCC 25923). Statistical analysis confirmed the significance of the observed antibacterial activity against E. coli and P. aeruginosa.
 Dose-response study results highlighted the efficacy and potency of aqueous extractions from bark and leaves against Escherichia coli. In contrast, leaves and bark demonstrated the highest efficacy and potency, respectively against Pseudomonas aeruginosa. In conclusion, the study scientifically validated the hypotheses formulated at the study's outset, utilizing evidence from plant-based Ayurveda and traditional medicine. The findings underscore the potential of C. timorensis as a source of antibacterial agents in the context of addressing multi-drug resistance-related infectious diseases.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call